Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Dow
Moodys
McKinsey
Harvard Business School
Express Scripts
Medtronic

Last Updated: December 5, 2019

DrugPatentWatch Database Preview

Technetium tc-99m medronate kit - Generic Drug Details

See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for technetium tc-99m medronate kit and what is the scope of patent protection?

Technetium tc-99m medronate kit is the generic ingredient in five branded drugs marketed by Ge Healthcare, Pharmalucence, and Cardinal Health 414, and is included in five NDAs. Additional information is available in the individual branded drug profile pages.

There are four drug master file entries for technetium tc-99m medronate kit. One supplier is listed for this compound.

Summary for technetium tc-99m medronate kit
Recent Clinical Trials for technetium tc-99m medronate kit

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of UtahPhase 2
University of ManitobaPhase 3
Winnipeg Regional Health AuthorityPhase 3

See all technetium tc-99m medronate kit clinical trials

Pharmacology for technetium tc-99m medronate kit

US Patents and Regulatory Information for technetium tc-99m medronate kit

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ge Healthcare TECHNETIUM TC 99M MPI MDP technetium tc-99m medronate kit INJECTABLE;INJECTION 018141-002 Jun 12, 1989 DISCN No No   Start Trial   Start Trial   Start Trial
Pharmalucence OSTEOLITE technetium tc-99m medronate kit INJECTABLE;INJECTION 017972-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Pharmalucence CIS-MDP technetium tc-99m medronate kit INJECTABLE;INJECTION 018124-001 Approved Prior to Jan 1, 1982 RX No No   Start Trial   Start Trial   Start Trial
Ge Healthcare TECHNETIUM TC 99M MPI MDP technetium tc-99m medronate kit INJECTABLE;INJECTION 018141-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Cardinal Health 414 MDP-BRACCO technetium tc-99m medronate kit INJECTABLE;INJECTION 018107-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Ge Healthcare AMERSCAN MDP KIT technetium tc-99m medronate kit INJECTABLE;INJECTION 018335-001 Aug 5, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Express Scripts
Johnson and Johnson
Harvard Business School
Dow
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.